Fenestra Pharmaceuticals Private Limited, a active private limited company, was established on 10 January 2011 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230KA2011PTC056572. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.25 M.
It upholds a compliant status. Employing 25 professional, Its leadership includes Jayasankar Panichelparambil Gopalakrishnakurup (Director), Sugunanambiar Bijoy (Director), Nimesh Elayidath (Managing Director). Past directors included Lakshmi Rajeev, Sooraj Dharmalayam. It holds ₹1.38 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at #751, Ground Floor, 8Th Cross, 4Th Main, Mc Layout, Bangalore, Karnataka, 560040.
U24230KA2011PTC056572
056572
10 January 2011
₹2.50 M
₹2.25 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Fenestra Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jayasankar Panichelparambil Gopalakrishnakurup | Director | 10 Jan 2011 | Current |
| Sugunanambiar Bijoy | Director | 10 Jan 2011 | Current |
| Nimesh Elayidath | Managing Director | 10 Jan 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Mar 2015 | Past |
| Pramod Abcsdd | Director | 28 Jun 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fenestra Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.18% increase. The company also saw a substantial improvement in profitability, with a 58.64% increase in profit. The company's net worth Soared by an impressive increase of 11.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Fenestra Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹13,805,509.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2025 | Hdfc Bank Limited | ₹2.50 M | Open |
| 30 Jan 2025 | Hdfc Bank Limited | ₹2.50 M | Open |
| 29 Dec 2022 | Hdfc Bank Limited | ₹2.50 M | Open |
| 29 Dec 2022 | Hdfc Bank Limited | ₹2.51 M | Open |
| 29 Dec 2022 | Hdfc Bank Limited | ₹2.51 M | Open |
Explore comprehensive loan charge details -
Fenestra Pharmaceuticals has a workforce of 25 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Fenestra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fenestra Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Fenestra Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Fenestra Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 2.50 M with Charge ID 101056788 was registered on 30 Jan 2025. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 2.50 M with Charge ID 101053146 was registered on 30 Jan 2025. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.50 M with Charge ID 100722808 was registered on 29 Dec 2022. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.51 M with Charge ID 100715562 was registered on 29 Dec 2022. was documented.
The CIN of Fenestra Pharmaceuticals Private Limited is U24230KA2011PTC056572.
Fenestra Pharmaceuticals Private Limited is headquartered at #751, Ground Floor, 8Th Cross, 4Th Main, Mc Layout, Bangalore, Karnataka, 560040.
Fenestra Pharmaceuticals Private Limited was incorporated on 10 January 2011.
The current directors of Fenestra Pharmaceuticals Private Limited are
The primary industry of Fenestra Pharmaceuticals Private Limited is Trade.
Fenestra Pharmaceuticals Private Limited is unlisted.
The authorized capital of Fenestra Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.25 M.
The compliance status of Fenestra Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX